Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

900 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy.
Jabbour E, Kantarjian HM, Jones D, Shan J, O'Brien S, Reddy N, Wierda WG, Faderl S, Garcia-Manero G, Verstovsek S, Rios MB, Cortes J. Jabbour E, et al. Blood. 2009 Mar 5;113(10):2154-60. doi: 10.1182/blood-2008-04-154344. Epub 2008 Dec 5. Blood. 2009. PMID: 19060245 Free PMC article. Clinical Trial.
Standard management of patients with chronic myeloid leukemia.
Fava C, Cortés JE, Kantarjian H, Jabbour E. Fava C, et al. Among authors: jabbour e. Clin Lymphoma Myeloma. 2009;9 Suppl 4:S382-90. doi: 10.3816/CLM.2009.s.038. Clin Lymphoma Myeloma. 2009. PMID: 20007107 Review.
Predictive factors for outcome and response in patients treated with second-generation tyrosine kinase inhibitors for chronic myeloid leukemia in chronic phase after imatinib failure.
Jabbour E, Kantarjian H, O'Brien S, Shan J, Garcia-Manero G, Wierda W, Ravandi F, Borthakur G, Rios MB, Cortes J. Jabbour E, et al. Blood. 2011 Feb 10;117(6):1822-7. doi: 10.1182/blood-2010-07-293977. Epub 2010 Oct 28. Blood. 2011. PMID: 21030554 Free PMC article. Clinical Trial.
900 results